Compounds of formula (I)
wherein R1, HET-1 and HET-2 are as described in the specification,
and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.
式(I)化合物
其中 R1、HET-1 和 HET-2 如说明书所述、
及其盐类和原药是
葡萄糖激酶(GLK)的激活剂,因此可用于治疗例如 2 型糖尿病。还描述了制备式(I)化合物的工艺。